e-Therapeutics (ETX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.75p
   
  • Change Today:
    -0.20p
  • 52 Week High: 23.10
  • 52 Week Low: 8.13
  • Currency: UK Pounds
  • Shares Issued: 584.34m
  • Volume: 175,706
  • Market Cap: £56.97m

Latest ShareCast News

e-Therapeutics proposes £29m fundraising, delisting from AIM

By Josh White

Date: Wednesday 10 Apr 2024

(Sharecast News) - RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.

E-Therapeutics enters collaboration with Arcturis Data

By Josh White

Date: Thursday 02 Nov 2023

(Sharecast News) - E-Therapeutics announced a strategic collaboration with Arcturis Data on Thursday - a prominent UK data company known for its high-quality, real-world data platform.

Eight new patent applications filed by e-therapeutics

By Josh White

Date: Monday 01 Aug 2022

(Sharecast News) - Computational drug discovery and development company e-therapeutics announced the filing of eight further patent applications in the United States on Monday, to protect innovation arising from its proprietary 'GalNAc-siRNA' technology.

E-therapeutics reaches 'key milestone' in Galapa... 12-Apr-2022 ShareCast
E-therapeutics finance chief stepping down due t... 22-Nov-2021 ShareCast
eTherapeutics CFO to stand down on 31 December 22-Nov-2021 ShareCast
E-therapeutics meets 'key milestone' in Galapago... 02-Jul-2021 ShareCast
E-therapeutics brings in Alison Gallafent as hea... 02-Jun-2021 ShareCast
E-therapeutics raises £22.5m to expand capabilit... 14-May-2021 ShareCast
E-therapeutics to receive two milestone payments... 23-Apr-2021 ShareCast
e-Therapeutics 're-energised' by Mortazavi appoi... 12-Oct-2020 ShareCast
E-therapeutics enters collaboration deal with Ga... 10-Jun-2020 ShareCast
E-therapeutics to collaborate with unnamed pharm... 13-Aug-2019 ShareCast
E-Therapeutics launches research collaboration w... 10-Dec-2018 ShareCast
E-Therapeutics and C4X upbeat on Parkinson's col... 06-Dec-2018 ShareCast
e-Therapeutics narrows interim losses as it eyes... 04-Oct-2018 ShareCast
e-Therapeutics 'well positioned' in big data spa... 05-Oct-2017 ShareCast
Raymond Barlow begins tenure as e-Therapeutics CEO 06-Apr-2017 ShareCast
E-Therapeutics depression drug trials miss targets 15-Feb-2016 ShareCast
Daily Mail General Trust's Chairman sells £15.91... 04-Jul-2014 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

e-Therapeutics Market Data

Currency UK Pounds
Share Price 9.75p
Change Today -0.20p
% Change -2.01 %
52 Week High 23.10
52 Week Low 8.13
Volume 175,706
Shares Issued 584.34m
Market Cap £56.97m

e-Therapeutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average23.56% below the market average
39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average39.62% above the sector average
Price Trend
59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average59.08% below the market average
29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average29.82% above the sector average
Income Not Available
Growth
15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average
24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average24.32% below the sector average

e-Therapeutics Dividends

No dividends found

Trades for 19-Apr-2024

Time Volume / Share Price
15:38 4,000 @ 10.17p
15:34 100,000 @ 10.19p
14:56 1,500 @ 9.60p
14:26 6,000 @ 9.60p
14:07 2,442 @ 9.60p

e-Therapeutics Key Personnel

Chair Trevor Mervyn Jones
CEO Ali Mortazavi

Top of Page